About Veravas

Veravas is a laboratory diagnostic company with a patient sample transformation technology, VeraBIND (Biomarker Isolation and N-richment for Detection) dedicated to making early detection of disease related biomarkers possible in challenging sample types.  VeraBIND starts with any complex sample (saliva, blood, urine, and stool) and uses the company’s proprietary magnetic beads to purify and concentrate biomarkers of interest to create a new matrix-free sample. Detection of biomarkers free of the sample matrix allows for rapid development of highly accurate assays to detect low-abundance biomarkers by any detection methodology.

Veravas’ products are designed with convenience, sensitivity, accuracy, and cost-effectiveness in mind, allowing researchers, lab directors, commercial test manufacturers, and Veravas themselves to develop highly sensitive assays for early detection of disease, clinical trials, precision diagnosis, and treatment monitoring.